Clinical Trial Update: Bioequivalence Study of Tansulosine 0,4 mg Capsule in Health Subjects -Fed State [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 bioequivalence study of Tansulosine 0.4 mg capsules in healthy subjects under fed conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Tansulosine 0.4 mg Capsule (Tansulosine)

Snippet

Sponsor: Biocinese | Conditions: Hyperplasia Prostatic | Phase 4 | Status: UNKNOWN